Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

NCT00268476 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

11992

Enrollment

OTHER_GOV

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Celecoxib
DRUG: Docetaxel
DRUG: Prednisolone
DRUG: ADT
DRUG: Zoledronic Acid
DRUG: Abiraterone
RADIATION: Radiotherapy to the prostate
DRUG: Enzalutamide
DRUG: Metformin
DRUG: Transdermal Oestradiol

Sponsor

Medical Research Council